Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

CMS issues proposed decision memo on ocular photodynamic therapy and opens national coverage analyses for cardiac pacemakers and bariatric surgery. GAO denies Palmetto’s Medicare award protest. More reimbursement news.

You may also be interested in...



Cardiac Pacemaker National Medicare Coverage Policy Updated

CMS issued a final decision memo Aug. 13 to cover implantation of permanent single- and dual-chamber cardiac pacemakers for documented nonreversible symptomatic bradycardia due to sinus node dysfunction and second- and/or third-degree atrioventricular block.

News In Brief

NICE changes name, leader, and expands mission to social care. Cordis wins Cypher patent case on appeal. More news in brief.

News In Brief

CMS final coverage decision impacting PET oncologic imaging and more news.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032465

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel